MycoBiomDB – Record Details (MyCo_2680)

Biomarker Record Details

Database ID: MyCo_2680
DB IDMyCo_2680
TitleGalactomannan antigen enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis after hematopoietic stem cell transplantation
Year2007
PMID17287156
Fungal Diseases involvedInvasive aspergillosis
Associated Medical ConditionHematopoietic stem cell transplantation (HSCT)
GenusAspergillus
Speciesspp.
OrganismAspergillus spp.
Ethical StatementNone
Site of InfectionNone
Opportunistic invasiveOpportunistic
Sample typeBody fluid
Sample sourceSerum
Host GroupHuman
Host Common nameHuman
Host Scientific nameHomo sapiens
Biomarker NameGM
Biomarker Full NameGalactomamman
Biomarker TypeDiagnostic
BiomoleculeProtein
Geographical LocationMinnesota
CohortIn 2004, all patients undergoing HSCT at the University of Minnesota Medical Center were screened with biweekly serum GM ELISAs while hospitalized. Additional testing of GM on HSCT patients outside the hospital was done as determined by clinical providers. Assays were performed on peripheral blood serum in accordance with the manufacturer’s specifi- cations (Bio-Rad, Redmond, WA).
Cohort No.121
Age GroupNone
P ValueNone
Sensitivity0.005
Specificity0.0094
Positive Predictive Value0.0046
MICNone
Fold ChangeNone
PathwayNone
Disease Introduction MechanismInvasive aspergillosis (IA) is a frequent and devastating complication in patients who have undergone hematopoietic stem cell transplantation (HSCT). The diagnosis of IA remains a clinical challenge. Blood, sputum, and bronchoalveolar lavage cultures have low specificity and sensitivity in detecting IA. Radiographic findings on computed tomography (CT) of the chest are also frequently nonspecific.
TechniqueELISA
Analysis MethodELISA Based
ELISA kitsELISA Kit (Bio-Rad, Redmond, WA)
Assay DataNone
Validation Techniques usedELISA
Up Regulation Down RegulationIncrease
Sequence DataNone
External LinkNone